Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a...

|About: Incyte Corporation (INCY)|By:, SA News Editor

Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a Buy rating and the announcement that the firm is presenting positive results for its ruxolitinib treatment for various cancers at a Hematology conference today.